What is this study trying to find out about haematuria?

This study aims to understand how patients admitted with emergency haematuria are managed across different hospitals internationally. Researchers want to identify variations in care, patient outcomes like hospital stay length, mortality, and readmission rates. The goal is to guide better care practices and future studies for haematuria management.

Who may be eligible for this haematuria clinical trial?

Adults aged 18 and older admitted as an emergency to a participating hospital with haematuria under urology care may be eligible. There is no gender restriction. People with catheter-related urethral trauma or hospital stays shorter than 24 hours are excluded. Please review eligibility criteria for more details.

Is there any cost to participate in this haematuria clinical trial?

Study-related care, including all data collection and trial visits, is provided at no cost. However, personal expenses such as travel may vary and are not guaranteed to be covered.

Actively Recruiting

Age: 18Years +

All Genders

ID07395037

International Study on Emergency Hospital Admissions for Blood in Urine Prospective Observational Research on Management and Outcomes

Led by British Urology Researchers in Surgical Training · Updated on 2026-02-09

1050

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are conducting an international, multicenter observational study to understand how patients admitted to hospitals with emergency haematuria are managed. The study aims to identify variations in care, measure outcomes like length of hospital stay, mortality, readmission rates, and resource use, and support the development of future guidelines and trials to improve haematuria management. The study collects detailed data on patient demographics, underlying health conditions, diagnostic procedures, treatments, and outcomes using a standardized form. It includes patients admitted as emergencies with haematuria under urology care. The study observes current hospital management pathways and gathers information through questionnaires to participating sites. Participants will be followed during their hospital stay and for 90 days afterward. Researchers will evaluate length of stay, time to diagnosis, mortality at 30 and 90 days, readmissions, days alive and out of hospital, and healthcare costs. The study uses data analysis to assess factors linked to outcomes and variations in care. Participation involves no changes to treatment as it is observational, and data will be collected consecutively over a 12-month period from multiple centers.

CONDITIONS

Brief Title

A Study of Ward Admissions for Haematuria

Who Can Participate

Age: 18Years +

All Genders

Eligibility Criteria

You may qualify if you...

Patients are included if they are over 16 years of age or older and admitted to a participating urological secondary care centre
Admitted as an emergency with haematuria as the primary or secondary diagnosis under the primary or joint care of urology

You will not qualify if you...

Any patients under 16 years of age
Patients with catheter-related urethral trauma defined as haematuria immediately after insertion of a urethral catheter that was documented as traumatic by the clinician, with no previous history of haematuria prior to catheter insertion
Patients that are in hospital less than 24 hours

Research Team

Kevin Byrnes, PhD

Nikita Bhatt, FRCS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here